MiR-129-5p Improves Cardiac Function in Rats with Chronic Heart Failure Through Targeting HMGB1

Overview

Journal Mamm Genome

Specialty Genetics

Date 2019 Oct 25

PMID 31646380

Citations 22

Authors

Na Xiao

Jun Zhang

Chao Chen

Yanfang Wan

Ning Wang

Jing Yang

Affiliations

Soon will be listed here.

Abstract

Increasing evidence shows that miRNAs play pivotal roles in cardiovascular diseases, including heart failure (HF). The aim of this study was to investigate the role of miR-129-5p in chronic heart failure and the underlying mechanisms. The levels of miR-129-5p and HMGB1 in chronic heart failure patients (CHF) and normal controls were examined by RT-qPCR and ELISA. Cardiac function, hemodynamics parameters, oxidative stress, and inflammation factors were analyzed in CHF rat model after transfection of miR-129-5p or HMGB1. Dual-luciferase activity reporter assay was conducted to validate the interaction between miR-129-5p and HMGB1. Downregulation of miR-129-5p and upregulation of HMGB1 were observed in the serum of CHF patients, respectively. Transfection of miR-129-5p improved heart function and hemodynamic parameters, as well as attenuated oxidative stress and inflammation factors in CHF rats. We further confirmed that HMGB1 is a direct target of miR-129-5p. Transfection of miR-129-5p also decreased the mRNA and protein levels of HMGB1 in myocardial tissues of CHF rats. Overexpression of HMGB1 diminished the effects of miR-129-5p on ameliorating oxidative stress and inflammatory response in rats with CHF. Our findings suggest that miR-129-5p protects the heart by targeting HMGB1.

Citing Articles

Bone marrow-derived mesenchymal stem cell-derived exosome-loaded miR-129-5p targets high-mobility group box 1 attenuates neurological-impairment after diabetic cerebral hemorrhage.

Wang Y, Li K, Wang J, Hua W, Liu Q, Sun Y World J Diabetes. 2024; 15(9):1979-2001.

PMID: 39280179 PMC: 11372641. DOI: 10.4239/wjd.v15.i9.1979.

Iron Dysregulation in Cardiovascular Diseases.

Wang H, Huang Z, Du C, Dong M Rev Cardiovasc Med. 2024; 25(1):16.

PMID: 39077672 PMC: 11263000. DOI: 10.31083/j.rcm2501016.

Exosomal miR-129 and miR-342 derived from intermittent hypoxia-stimulated vascular smooth muscle cells inhibit the eIF2α/ATF4 axis from preventing calcified aortic valvular disease.

Huang C, Han X, Yang L, Song W, Zhang H, Zhu X J Cell Commun Signal. 2023; 17(4):1449-1467.

PMID: 37812275 PMC: 10713511. DOI: 10.1007/s12079-023-00785-4.

Circulating microRNA Profiles for Premature Cardiovascular Death in Patients with Kidney Failure with Replacement Therapy.

Kuscu C, Mallisetty Y, Naik S, Han Z, Berta C, Kuscu C J Clin Med. 2023; 12(15).

PMID: 37568412 PMC: 10419472. DOI: 10.3390/jcm12155010.

Myocardial fibrosis and calcification are attenuated by microRNA-129-5p targeting Asporin and Sox9 in cardiac fibroblasts.

Medzikovic L, Aryan L, Ruffenach G, Li M, Savalli N, Sun W JCI Insight. 2023; 8(9).

PMID: 37154157 PMC: 10243800. DOI: 10.1172/jci.insight.168655.

References

Savarese G, Lund L . Global Public Health Burden of Heart Failure. Card Fail Rev. 2017; 3(1):7-11. PMC: 5494150. DOI: 10.15420/cfr.2016:25:2. View

Elahi M, Kong Y, Matata B . Oxidative stress as a mediator of cardiovascular disease. Oxid Med Cell Longev. 2010; 2(5):259-69. PMC: 2835914. DOI: 10.4161/oxim.2.5.9441. View

Ramani G, Uber P, Mehra M . Chronic heart failure: contemporary diagnosis and management. Mayo Clin Proc. 2010; 85(2):180-95. PMC: 2813829. DOI: 10.4065/mcp.2009.0494. View

Bonneau E, Neveu B, Kostantin E, Tsongalis G, De Guire V . How close are miRNAs from clinical practice? A perspective on the diagnostic and therapeutic market. EJIFCC. 2019; 30(2):114-127. PMC: 6599191. View

Li G, Xie J, Wang J . Tumor suppressor function of miR-129-5p in lung cancer. Oncol Lett. 2019; 17(6):5777-5783. PMC: 6507349. DOI: 10.3892/ol.2019.10241. View

Verjans R, Derks W, Korn K, Sonnichsen B, van Leeuwen R, Schroen B . Functional Screening Identifies MicroRNAs as Multi-Cellular Regulators of Heart Failure. Sci Rep. 2019; 9(1):6055. PMC: 6465262. DOI: 10.1038/s41598-019-41491-9. View

Shah R, Das S, Lewis G . Circulating MicroRNAs: New Avenues for Heart Failure Classification?. J Am Coll Cardiol. 2019; 73(11):1314-1316. DOI: 10.1016/j.jacc.2018.10.091. View

Luo J, Chen J, He L . mir-129-5p Attenuates Irradiation-Induced Autophagy and Decreases Radioresistance of Breast Cancer Cells by Targeting HMGB1. Med Sci Monit. 2016; 21:4122-9. PMC: 4700864. DOI: 10.12659/msm.896661. View

Ma X, Li S, Shang F . RETRACTED: Effect of microRNA-129-5p targeting HMGB1-RAGE signaling pathway on revascularization in a collagenase-induced intracerebral hemorrhage rat model. Biomed Pharmacother. 2017; 93:238-244. DOI: 10.1016/j.biopha.2017.06.012. View

10.

Wang S, Chen Y, Yu X, Lu Y, Wang H, Wu F . miR-129-5p attenuates cell proliferation and epithelial mesenchymal transition via HMGB1 in gastric cancer. Pathol Res Pract. 2019; 215(4):676-682. DOI: 10.1016/j.prp.2018.12.024. View

11.

Zhang H, Zhang X, Zhang J . MiR-129-5p inhibits autophagy and apoptosis of H9c2 cells induced by hydrogen peroxide via the PI3K/AKT/mTOR signaling pathway by targeting ATG14. Biochem Biophys Res Commun. 2018; 506(1):272-277. DOI: 10.1016/j.bbrc.2018.10.085. View

12.

Rock K, Kono H . The inflammatory response to cell death. Annu Rev Pathol. 2007; 3:99-126. PMC: 3094097. DOI: 10.1146/annurev.pathmechdis.3.121806.151456. View

13.

Yao H, Zhou M, Zhou Y, Wang L, Zhang D, Han Q . Intravenous high mobility group box 1 upregulates the expression of HIF-1α in the myocardium via a protein kinase B-dependent pathway in rats following acute myocardial ischemia. Mol Med Rep. 2015; 13(2):1211-9. PMC: 4732844. DOI: 10.3892/mmr.2015.4648. View

14.

Huang Y, Li W, Wu J, Han M, Li B . The diagnostic value of circulating microRNAs in heart failure. Exp Ther Med. 2019; 17(3):1985-2003. PMC: 6364251. DOI: 10.3892/etm.2019.7177. View

15.

Zhang D, Cao J, Zhong Q, Zeng L, Cai C, Lei L . Long noncoding RNA PCAT-1 promotes invasion and metastasis via the miR-129-5p-HMGB1 signaling pathway in hepatocellular carcinoma. Biomed Pharmacother. 2017; 95:1187-1193. DOI: 10.1016/j.biopha.2017.09.045. View

16.

Li W, Sama A, Wang H . Role of HMGB1 in cardiovascular diseases. Curr Opin Pharmacol. 2006; 6(2):130-5. PMC: 1782046. DOI: 10.1016/j.coph.2005.10.010. View

17.

Raucci A, Di Maggio S, Scavello F, dAmbrosio A, Bianchi M, Capogrossi M . The Janus face of HMGB1 in heart disease: a necessary update. Cell Mol Life Sci. 2018; 76(2):211-229. PMC: 6339675. DOI: 10.1007/s00018-018-2930-9. View

18.

Zhang J, Xing Q, Zhou X, Li J, Li Y, Zhang L . Circulating miRNA‑21 is a promising biomarker for heart failure. Mol Med Rep. 2017; 16(5):7766-7774. DOI: 10.3892/mmr.2017.7575. View

19.

Wu Q, Meng W, Jie Y, Zhao H . LncRNA MALAT1 induces colon cancer development by regulating miR-129-5p/HMGB1 axis. J Cell Physiol. 2017; 233(9):6750-6757. DOI: 10.1002/jcp.26383. View

20.

Azad N, Lemay G . Management of chronic heart failure in the older population. J Geriatr Cardiol. 2015; 11(4):329-37. PMC: 4292097. DOI: 10.11909/j.issn.1671-5411.2014.04.008. View